Natural history and screening model for high-risk human papillomavirus infection, neoplasia and cervical cancer in the Netherlands

Johannes Berkhof, Martine C. De Bruijne, Gilda D. Zielinski, Chris J.L.M. Meijer*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

A simulation model is presented that assumes that persistent infection with high-risk human papillomavirus (hrHPV) is a necessary cause of cervical cancer. For the estimation of the model parameters, data of recent Dutch follow-up studies were reanalyzed. The predicted incidences of cervical cancer, cervical intraepithelial neoplasia (CIN1, CIN2 and CIN3) and abnormal cytology were validated with nationwide figures and population-based screening results. The model predicted a lifetime risk for cervical cancer of 2.9% with a peak at age 48 years. The predicted lifetime risk dropped to 0.4% when attending cervical screening. For women who were not hrHPV infected at 30 years, the lifetime risk was 1.6%. Sensitivity analyses were performed to check natural history assumptions that were only weakly identified from available data sets. The incidence of CIN3 observed with screening appeared a useful clinical end point as the predicted incidence was robust against changes in the sensitivity of cervical cytology and the duration to CIN3. The model can be used to study the health-economic benefits that can be achieved in nationwide screening when including an hrHPV test.

Original languageEnglish
Pages (from-to)268-275
Number of pages8
JournalInternational Journal of Cancer
Volume115
Issue number2
DOIs
Publication statusPublished - 10 Jun 2005

Cite this